UK psychiatrists' experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
- PMID: 32938512
- PMCID: PMC7576649
- DOI: 10.1192/bjo.2020.97
UK psychiatrists' experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
Abstract
Background: A high proportion of adults with intellectual disabilities are prescribed off-licence antipsychotics in the absence of a psychiatric illness. The National Health Service in England launched an initiative in 2016, 'Stopping over-medication of people with a learning disability [intellectual disability], autism or both' (STOMP), to address this major public health concern.
Aims: To gain understanding from UK psychiatrists working with adults with intellectual disabilities on the successes and challenges of withdrawing antipsychotics for challenging behaviours.
Method: An online questionnaire was sent to all UK psychiatrists working in the field of intellectual disability (estimated 225).
Results: Half of the 88 respondents stated that they started withdrawing antipsychotics over 5 years ago and 52.3% stated that they are less likely to initiate an antipsychotic since the launch of STOMP. However, since then, 46.6% are prescribing other classes of psychotropic medication instead of antipsychotics for challenging behaviours, most frequently the antidepressants. Complete antipsychotic discontinuation in over 50% of patients treated with antipsychotics was achieved by only 4.5% of respondents (n = 4); 11.4% reported deterioration in challenging behaviours in over 50% of patients on withdrawal and the same proportion (11.4%) reported no deterioration. Only 32% of respondents made the diagnosis of psychiatric illness in all their patients themselves. Family and paid carers' concern, lack of multi-agency and multidisciplinary input and unavailability of non-medical psychosocial intervention are key reported factors hampering the withdrawal attempt.
Conclusions: There is an urgent need to develop national guidelines to provide a framework for systematic psychotropic drug reviews and withdrawal where possible.
Keywords: Intellectual disabilities; STOMP; adults; antipsychotics; withdrawal.
Conflict of interest statement
Supplementary material
References
-
- Smith S, Branford D, Collacott RA, Cooper SA, McGrother C. Prevalence and cluster typology of maladaptive behaviours in a geographically defined population of adults with learning disabilities. Br J Psychiatry 1996; 169: 219–27. - PubMed
-
- Deb S, Thomas M, Bright C. Mental disorder in adults with intellectual disability. 2: The rate of behaviour disorders among a community-based population aged between 16-64 years. J Intellect Disabil Res 2001; 45: 506–14. - PubMed
-
- Hemmings C, Deb S, Chaplin E, Hardy S, Mukherjee R. Research for people with intellectual disabilities and mental health problems: a view from the UK. J Ment Health Res Intellect Disabil 2013; 6: 127–58.
-
- Deb S, Bethea T, Havercamp S, Rifkin A, Underwood L. Disruptive, impulse-control, and conduct disorders In Diagnostic Manual – Intellectual Disability: A Textbook of Diagnosis of Mental Disorders in Persons with Intellectual Disability (2nd edn) (eds Fletcher R, Barnhill J, Cooper S-A): 521–60. NADD Press, 2016.
-
- Lundqvist LO. Prevalence and risk markers of behavior problems among adults with intellectual disabilities: a total population study in Örebro County, Sweden. Res Dev Disabil 2013; 34: 1346–56. - PubMed
LinkOut - more resources
Full Text Sources
